Recursion Pharmaceuticals (RXRX) Notes Payables (2020 - 2024)
Recursion Pharmaceuticals (RXRX) reported Notes Payables of $55000.0 for Q1 2024, down 91.68% on a YoY basis from $661000.0 in Q2 2023, and up 34.15% quarter-over-quarter from $41000.0 in Q4 2023.
Recursion Pharmaceuticals (RXRX) Notes Payables (2020 - 2024) Analysis & Trends
Recursion Pharmaceuticals has reported Notes Payables for 5 years, with the latest figure at $55000.0 in Q1 2024.
- For the quarter ending Q1 2024, Notes Payables fell 91.68% year-over-year to $55000.0; the trailing twelve-month figure through Mar 2024 stood at $55000.0 (down 91.68% YoY), and the FY2023 full-year result was $41000.0, down 57.73% from the prior year.
- Notes Payables for Q1 2024 stood at $55000.0, up from $41000.0 in the prior quarter.
- The five-year high for Notes Payables was $3.1 million in Q2 2021, with the low at $41000.0 in Q4 2023.
- Historically, Notes Payables has averaged $645428.6 across 5 years, with a median of $96000.0 in 2022.
- Annual changes were most pronounced in 2022 — Notes Payables sank 97.03% — and 2023, when it jumped 631.58%.
- Recursion Pharmaceuticals' Notes Payables stood at $1.1 million in 2020, then plunged by 91.61% to $90000.0 in 2021, then grew by 7.78% to $97000.0 in 2022, then plunged by 57.73% to $41000.0 in 2023, then soared by 34.15% to $55000.0 in 2024.
- The last three Notes Payables figures came in at $55000.0 (Q1 2024), $41000.0 (Q4 2023), and $695000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 695,000.00 |
| Jun 30, 2023 | 676,000.00 |
| Mar 31, 2023 | 661,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 93,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Sep 30, 2021 | 88,000.00 |
| Jun 30, 2021 | 3.14 Mn |
| Mar 31, 2021 | 2.15 Mn |
| Dec 31, 2020 | 1.07 Mn |